Latvia Faces Epidemic of Tobacco and Nicotine Consumption: 44% Youth Use Rate

Industry Insight by 2FIRSTS.ai
Jul.01.2024
Latvia Faces Epidemic of Tobacco and Nicotine Consumption: 44% Youth Use Rate
Latvia faces a tobacco epidemic with increasing number of smokers and rising youth e-cigarette use, according to a report on July 1 by ENG.ISM.

According to a report by ENG.ISM on July 1st, Latvia is facing an epidemic of tobacco and nicotine consumption. The number of smokers is once again on the rise, with e-cigarette usage doubling in certain age groups in just a few years. The age at which children first try e-cigarettes is also changing.

 

E-cigarettes are particularly popular among young people aged 15-24.

 

Iveta Pudule, senior public health analyst at the Disease Prevention and Control Center (SPKC), stated:

 

Since 2016, this percentage has increased from 22% to 44%, nearly doubling in size.

 

Many parents of children who smoke believe that the nicotine in e-cigarettes is less harmful than in regular cigarettes. They think that vaping is harmless, but in fact, it is not.

 

Renāte Snipe, Chief Pulmonologist at Children's Clinical University Hospital (BKUS), believes that e-cigarettes have a significant impact on children's lung function and brain development.

 

Disposable e-cigarettes are incredibly difficult to tackle because they are cheap. The affordable price makes them most attractive and accessible to young people. Additionally, of course, they also cause significant pollution.

 

Even though the new restrictions in Latvia are making it more difficult for the tobacco industry to operate, experts at Riga Stradins University (RSU) recently conducted a study and concluded that there is still room for improvement in the industry.

 

Director of the RSU Institute of Public Health, Anda Ķīvīte-Urtāne, stated that

 

Experts from the World Health Organization have calculated that taxes should be increased by at least 10% and applied to all nicotine products. We have not kept up with this increase in prices. In fact, considering inflation, the new rate of increase is too slow to have an impact on consumption habits.

 

Public health experts have concluded that overall, nicotine control policies are quite comprehensive, but the most important issue is the lack of practical assistance for those who want to quit smoking. Additionally, there is insufficient education for school children on this matter.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Bloomberg: Zyn’s Dry-Mouth Problem Threatens Its Hold on Nicotine Pouch Market
Bloomberg: Zyn’s Dry-Mouth Problem Threatens Its Hold on Nicotine Pouch Market
According to Bloomberg, Philip Morris International’s Zyn is facing growing competition in the U.S. nicotine pouch market as consumers shift toward moister alternatives such as British American Tobacco’s Velo Plus.
BATPMI
May.22
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Canada’s Federal Vape Flavor Restrictions Remain Unclear Five Years After Announcement
Canada’s Federal Vape Flavor Restrictions Remain Unclear Five Years After Announcement
Five years after Canada’s federal government announced plans to restrict vaping flavors nationwide, Health Minister Marjorie Michel has not said when or whether the measure will still proceed. In 2021, Health Canada said it planned to limit vaping flavors nationwide to mint, menthol and tobacco, citing evidence that fruity and sweet flavors appeal to youth.
May.11 by 2FIRSTS.ai